Premium
Degradable and Excretable Ultrasmall Transition Metal Selenide Nanodots for High‐Performance Computed Tomography Bioimaging‐Guided Photonic Tumor Nanomedicine in NIR‐II Biowindow
Author(s) -
Dong Lile,
Sun Lining,
Li Wenjuan,
Jiang Yunping,
Zhan Yingying,
Yu Luodan,
Chen Yu,
Hong Guobin
Publication year - 2021
Publication title -
advanced functional materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.069
H-Index - 322
eISSN - 1616-3028
pISSN - 1616-301X
DOI - 10.1002/adfm.202008591
Subject(s) - materials science , nanodot , nanomedicine , nanotechnology , selenide , nanoparticle , photonics , optoelectronics , selenium , metallurgy
Transition metal selenide nanodots (NDs) represent distinctive antitumor agents for cancer treatment, but their non‐biodegradability may bring serious adverse effects and potential long‐term toxicity to internal tissues/organs, which substantially hinder their further clinical translations. In this work, the construction of a multifunctional theranostic nanosystem based on degradable and excretable ultrasmall Rh 3 Se 8 NDs by a general bovine serum albumin‐templated strategy is reported. The constructed Rh 3 Se 8 NDs exhibit distinctively high photothermal‐conversion efficiency (57.5%) in the second near‐infrared biowindow, making them highly applicable for photoacoustic imaging and photonic hyperthermia at the desired wavelength. Rh 3 Se 8 NDs exhibit a high tumor growth inhibition rate (98.1%) on 4T1 breast tumor‐bearing mice due to the desirable photonic hyperthermia performances. Especially, the fabricated Rh 3 Se 8 NDs feature the large X‐ray attenuation coefficients of the Rh component for contrast‐enhanced X‐ray computed tomography imaging. Importantly, the prominent biodegradability of Rh 3 Se 8 NDs enables their quick excretion out of the body for potentially avoiding inflammation and mitigating long‐term toxicity. Therefore, this work highlights the construction of proof‐of‐concept biodegradable and excretable ultrasmall inorganic theranostic nanosystems for multiple bioimaging‐guided cancer nanotherapeutics, guaranteeing the further clinical translations of inorganic nanoparticles in biomedicine.